In addition, the blockade of PGE2/EP4 signaling reduced the secretion of EVs by basal mammary epithelial stem cells while promoting the release of EVs and CSC-associated proteins from transformed mesenchymal breast cancer cells, modulating tumor progression. This evidence concerns the gene PTGER4 and neoplasm.